Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
06/2000
06/08/2000CA2347677A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/07/2000EP1006197A1 Use of an immuno complex for the preparation of a therapeutic composition useful for transfecting a polynucleotide into macropinocyte cells
06/07/2000EP1006196A2 Retroviral hybrid vectors pseudotyped with LCMV glycoprotein
06/07/2000EP1006186A1 Human genes
06/07/2000EP1006185A1 Tissue-specific splice variant of recombination-repair gene rad51b associated with t(12;14)-uterine leiomyomas
06/07/2000EP1006123A2 Envelope proteins, methods and uses
06/07/2000EP1005871A2 Trapped cells and use thereof as a drug
06/07/2000EP1005545A1 Human extracellular matrix-1
06/07/2000EP1005538A1 Gene therapy for alleviating erectile dysfunction
06/07/2000EP1005482A1 Selective induction of cell death by delivery of amino-terminal interleukin-1-alpha pro-piece polypeptide
06/07/2000EP1005480A1 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases
06/07/2000EP1005466A1 Tetraether lipid derivatives and liposomes and lipid agglomerates containing tetraetherlipid derivatives, and use thereof
06/07/2000EP1005377A2 Receptor-mediated gene delivery using bacteriophage vectors
06/07/2000EP1005376A1 Methods and compositions for use in gene therapy for treatment of hemophilia
06/07/2000EP1005375A1 Photodynamic therapy generated oxidative stress for temporal and selective expression of heterologous genes
06/07/2000EP1005374A1 Microparticles for delivery of nucleic acid
06/07/2000EP1005368A1 USE OF NUCLEIC ACIDS CONTAINING UNMETHYLATED CpG DINUCLEOTIDE AS AN ADJUVANT
06/07/2000EP1005366A1 Functional dna clone for hepatitis c virus (hcv) and uses thereof
06/07/2000EP1005360A1 Antioxidant protein 2, gene and methods of use therefor
06/07/2000EP1005358A1 Method for preventing and treating hearing loss using a neurturin protein product
06/07/2000EP1005357A1 Peptide antiestrogen compositions and methods for treating breast cancer
06/07/2000EP1005352A1 Osteocalcin promoter-based toxic gene therapy
06/07/2000EP1005330A1 Methods and compositions for targeting compounds to muscle
06/07/2000EP0806965A4 Cd44 expression in smooth muscle cells
06/06/2000US6072041 Single chain fv molecule directed against a transcytotic receptor covalently linked to a therapeutic protein; to deliver therapy to the other side of a cell
06/06/2000US6072037 Antibodies to the IL-17 receptor
06/06/2000US6072033 Receptor that binds IL-17
06/06/2000US6072032 Amino acid sequence of polypeptide involved in protein secretory apparatus of bacteria; for screening for bactericides and bacteriostats; diagnosis of and prophylaxis for infections
06/06/2000US6071894 Sensor histidine kinase of Staphylococcus aureus
06/06/2000US6071892 Polynucleotides that encode the polypeptide of tyrosyl synthetase have amino acid homology to a known bacillus subtilis tyrosyl trna synthetase protein
06/06/2000US6071891 Insulin-like growth factor 1 receptors (IGF-1R) antisense oligonucleotide cells composition
06/06/2000US6071890 Organ-specific targeting of cationic amphiphile/DNA complexes for gene therapy
06/06/2000US6071889 In vivo genetic modification of growth factor-responsive neural precursor cells
06/06/2000US6071747 Human preadipocytes for developing antiobesity and antidiabetic agents; cells include immortalizing fragment of viral oncogene, promoter from viral oncogene or human vimentin gene, and express certain proteins
06/06/2000US6071743 Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes
06/06/2000US6071742 Coxsackie virus as a vector for delivery of anti-inflammatory cytokines
06/06/2000US6071731 Enzymatic polypeptide for the attachment of histidine to transfer ribonucleic acid molecule; bactericides; wound healing agents
06/06/2000US6071722 Nucleic acids encoding a G-protein coupled 7TM receptor (AXOR-1)
06/06/2000US6071719 Polynucleotide sequence coding a membrane protein; for the treatment and prevention of infections
06/06/2000US6071708 Morphogenic protein compositions of matter
06/06/2000US6071697 Method for testing the differentiation status in pancreatic cells of a mammal
06/06/2000US6071593 Ceramic packing with channels for thermal and catalytic beds
06/06/2000US6071533 Mixing with hydrophilic polymer to increase shelf life
06/06/2000US6071512 Administering replication defective recombinant retrovirion with gene operable linked to control sequence
06/06/2000US6071497 Microparticles for lung delivery comprising diketopiperazine
06/04/2000CA2291356A1 Recombinant, adenoviral vector having limited autoreplication capability in vivo
06/02/2000WO2000031540A1 Immunostimulatory dna
06/02/2000WO2000031286A1 Adenoviral vector-mediated delivery of modified steroid hormone receptors and related products and methods
06/02/2000WO2000031285A1 Gene delivery vectors provided with a tissue tropism for smooth muscle cells, and/or endothelial cells
06/02/2000WO2000031280A2 Use of plus-strand synthesis elements in retroviral vectors
06/02/2000WO2000031267A1 Insulin production by engineered muscle cells
06/02/2000WO2000031265A1 Urotensins ii of mammals and their uses
06/02/2000WO2000031263A2 Gtpase associated proteins
06/02/2000WO2000031262A2 Human neurotensin subtype 2 receptor
06/02/2000WO2000031252A1 Human semaphorin 6a-1 (sema6a-a), a gene involved in neuronal development and regeneration mechanisms during apoptosis, and its use as a potential drug target
06/02/2000WO2000031238A2 Methods and reagents for increasing proliferative capacity and preventing replicative senescence
06/02/2000WO2000031235A2 Nucleotide and protein sequences of nogo genes and methods based thereon
06/02/2000WO2000031137A1 Amino-terminal modified parathyroid hormone (pth) analogs
06/02/2000WO2000031135A1 TGF$G(b)1 INHIBITOR PEPTIDES
06/02/2000WO2000031126A2 Suppression of xenotransplant rejection
06/02/2000WO2000031115A1 Methods of identifying antigen gene sequences
06/02/2000WO2000031113A1 INTRACELLULAR TARGETED DELIVERY OF COMPOUNDS BY 70 kD HEAT SHOCK PROTEIN
06/02/2000WO2000031109A1 USE OF CORE 2 GlcNAc TRANSFERASE INHIBITORS IN TREATING INFLAMMATION
06/02/2000WO2000031104A1 A novel g-protein coupled 7tm receptor (axor15)
06/02/2000WO2000030687A1 Novel adenoviral vector and methods for making and using the same
06/02/2000WO2000030671A2 Nf-at mediates cardiac hypertrophy, methods and reagents related thereto
06/02/2000WO2000030668A2 Use of parvovirus capsid particles in the inhibition of cell proliferation and migration
06/02/2000WO2000030662A1 Fabz
06/02/2000WO2000030590A2 Methods and compositions for diagnosis and treatment of cancer based on the transcription factor ets2
06/02/2000WO2000030425A2 Method of using pon-1 to decrease atheroma formation
06/02/2000WO2000014244A3 Treatment of cervical cancer
06/02/2000WO2000013703A9 Methods of treating hypertension and compositions for use therein
06/02/2000WO2000012545A3 Antibodies specific for bladder nuclear matrix proteins blca-1 to blca-6
06/02/2000WO2000011139A9 Cell population containing non-fetal hemangioblasts and method for producing same
06/02/2000WO2000006203A9 Dna cytokine vaccines and use of same for protective immunity against multiple sclerosis
06/02/2000WO1999063095A9 Nucleic acid vaccines for prevention of flavivirus infection
06/02/2000CA2352606A1 Urotensins ii of mammals and their uses
06/02/2000CA2352599A1 Nf-at mediates cardiac hypertrophy, methods and reagents related thereto
06/02/2000CA2352495A1 Human semaphorin 6a-1 (sema6a-a), a gene involved in neuronal development and regeneration mechanisms during apoptosis, and its use as a potential drug target
06/02/2000CA2352486A1 Methods and reagents for increasing proliferative capacity and preventing replicative senescence
06/02/2000CA2352084A1 Immunostimulatory dna
06/02/2000CA2352043A1 Use of parvovirus capsid particles in the inhibition of cell proliferation and migration
06/02/2000CA2351736A1 Methods of identifying antigen gene sequences
06/02/2000CA2351630A1 Vector
06/02/2000CA2351361A1 Gtpase associated proteins
06/02/2000CA2350405A1 Method of using pon-1 to decrease atheroma formation
06/02/2000CA2350395A1 Nucleotide and protein sequences of nogo genes and methods based thereon
06/02/2000CA2347940A1 Use of core 2 glcnac transferase inhibitors in treating inflammation
06/02/2000CA2291453A1 Dna-constructs of blood clotting factors and p-selectin
05/2000
05/31/2000EP1004670A2 Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents
05/31/2000EP1004593A2 Backbone modified oligonucleotide analogues
05/31/2000EP1004320A1 Use of magnesium (Mg2+) for the enhancement of gene delivery in gene therapy
05/31/2000EP1004319A1 Remedies for solid tumor containing wilms' tumor gene (wt1) expression inhibitors
05/31/2000EP1003916A1 Antisense oligonucleotide compositions and methods for the modulation of jnk proteins
05/31/2000EP1003899A1 Vectors and methods for providing cells with additional nucleic acid material integrated in the genome of said cells
05/31/2000EP1003898A1 Integrin-targeting vectors having transfection activity
05/31/2000EP1003897A1 Complexes for transporting nucleic acid into eukaryotic higher-cells
05/31/2000EP1003896A1 Coat-protein-modified baculovirus vector for gene therapy
05/31/2000EP1003895A2 Cloning vectors for producing adenoviral minimal viruses
05/31/2000EP1003894A2 Lentiviral vectors
1 ... 714 715 716 717 718 719 720 721 722 723 724 725 726 727 728 729 730 731 732 733 734 ... 870